Ipca Laboratories vs Alembic Pharmaceuticals: Share Price, PE and ROE Compared

The Ipca Laboratories vs Alembic Pharmaceuticals question comes up often among investors who follow the Pharmaceuticals space in India. Ipca Laboratories MCap Rs 44,822 Cr, PE 37. 86x, ROE 14. This article goes through what each company does, their latest financial performance, and the key numbers that matter for anyone evaluating Ipca Laboratories vs Alembic Pharmaceuticals as a research exercise.

All data cited here is sourced from publicly available company filings. Verify the latest prices and fundamentals on NSE or BSE before acting on any information.

Ipca Laboratories vs Alembic Pharmaceuticals: Company Overview and Market Presence

Ipca Laboratories operates in the Pharmaceuticals segment and is listed on Indian exchanges. Ipca Laboratories MCap Rs 44,822 Cr, PE 37 The company has built its market position over the years through its core offerings to customers across India.

Click Here – Get Free Investment Predictions

Alembic Pharmaceuticals is the other side of this Ipca Laboratories vs Alembic Pharmaceuticals comparison. 86x, ROE 14 It competes in the same Pharmaceuticals space, though its scale and strategy may differ significantly from Ipca Laboratories's approach.

When investors look at the Ipca Laboratories vs Alembic Pharmaceuticals pair, market capitalisation is usually the first filter. Ipca Laboratories MCap Rs 44,822 Cr, PE 37. 86x, ROE 14. The size difference, if any, tells you something about liquidity and institutional ownership patterns.

Ipca Laboratories vs Alembic Pharmaceuticals: Business Mix and Revenue Sources

To understand the Ipca Laboratories vs Alembic Pharmaceuticals comparison fully, you need to look at how each company makes money. Ipca Laboratories's revenue comes from its core Pharmaceuticals operations. Ipca Laboratories earns from the Pharmaceuticals segment.

Alembic Pharmaceuticals similarly derives its earnings from the Pharmaceuticals space. Alembic Pharmaceuticals operates in the Pharmaceuticals space. The product or service mix of the two companies can be similar or quite different depending on which subsegments each one serves.

Ipca Laboratories vs Alembic Pharmaceuticals: Financial Results and Key Ratios

This is where the Ipca Laboratories vs Alembic Pharmaceuticals comparison gets concrete. Return on equity, price-to-earnings ratio and market capitalisation are three metrics that help frame the relative position of each stock.

Ipca Laboratories MCap Rs 44,822 Cr, PE 37 The profitability and efficiency ratios here reflect the latest available data from public filings.

86x, ROE 14 Both sets of numbers should be cross-checked against the latest quarterly reports from BSE or NSE before drawing any conclusions.

Compare Ipca Laboratories and Alembic Pharmaceuticals on the Univest Screener

Ipca Laboratories vs Alembic Pharmaceuticals: Valuation and What the Market Is Pricing In

Valuation is a core part of any Ipca Laboratories vs Alembic Pharmaceuticals analysis. A high PE ratio can signal growth expectations or thin earnings. A low PE may indicate value or a business under stress. Neither is automatically good or bad without context.

Ipca Laboratories MCap Rs 44,822 Cr, PE 37.86x, ROE 14.15%. Alembic Pharmaceuticals MCap Rs 16,481 Cr, PE 23.90x, ROE 11.89%, Div 1.43%. The Ipca Laboratories vs Alembic Pharmaceuticals stock data above reflects figures sourced from publicly available data. Prices change daily, so treat this as a starting point for your own research rather than a definitive trading signal.

Dividend yield is another data point worth checking in the Ipca Laboratories vs Alembic Pharmaceuticals pair. Some investors prioritise income alongside capital appreciation, and a consistent dividend track record can be a sign of earnings quality and management confidence in the cash flow.

Ipca Laboratories vs Alembic Pharmaceuticals: Side-by-Side Comparison

The table below captures the most relevant metrics side by side for the Ipca Laboratories vs Alembic Pharmaceuticals comparison.

Parameter	Ipca Laboratories	Alembic Pharmaceuticals
MCap	Rs 44,822 Cr	Rs 16,481 Cr
PE	37.86x	23.90x
ROE	14.15%	11.89%
Div	0.34%	1.43%

What Should Investors Know About the Ipca Laboratories vs Alembic Pharmaceuticals Choice

Every Ipca Laboratories vs Alembic Pharmaceuticals research exercise should go beyond just looking at the current share price. The sector outlook for Pharmaceuticals companies, the trajectory of earnings growth, debt levels and management quality all feed into a complete picture.

For the Ipca Laboratories vs Alembic Pharmaceuticals pair specifically: Ipca Laboratories MCap Rs 44,822 Cr, PE 37. 86x, ROE 14. These numbers are a starting point. Investors should also look at the trend over four to eight quarters rather than just the latest standalone figure, since one strong quarter does not always reflect the underlying business quality.

If you are building a portfolio allocation decision around the Ipca Laboratories vs Alembic Pharmaceuticals comparison, consider the risk profile of your overall portfolio first. Both companies operate in Pharmaceuticals, which carries its own sector-specific risks including regulatory changes, commodity cost pressure, competitive intensity and macroeconomic sensitivity.

Conclusion

The Ipca Laboratories vs Alembic Pharmaceuticals comparison comes down to this: Ipca Laboratories and Alembic Pharmaceuticals are both listed Indian companies in the Pharmaceuticals space, but they differ in scale, valuation, and financial profile. Ipca Laboratories MCap Rs 44,822 Cr, PE 37. 86x, ROE 14.

Ipca Laboratories MCap Rs 44,822 Cr, PE 37.86x, ROE 14.15%. Alembic Pharmaceuticals MCap Rs 16,481 Cr, PE 23.90x, ROE 11.89%, Div 1.43%. Before taking any position in either stock, verify the latest fundamentals on NSE or BSE and consult a SEBI-registered investment advisor (registration number INH000013776).

Download the Univest iOS App or Univest Android App to track Ipca Laboratories and Alembic Pharmaceuticals live and get analyst-backed stock recommendations every day.

Frequently Asked Questions

What does Ipca Laboratories do?

Ans. Ipca Laboratories is a listed Indian company in the Pharmaceuticals segment. For the latest business updates, visit univest.in.

What does Alembic Pharmaceuticals do?

Ans. Alembic Pharmaceuticals is a listed Indian company in the Pharmaceuticals segment. For the latest business updates, visit univest.in.

Which is larger in the Ipca Laboratories vs Alembic Pharmaceuticals comparison?

Ans. Based on current market cap data: Ipca Laboratories MCap Rs 44,822 Cr, PE 37. Verify the latest figures on NSE or BSE.

How do PE ratios compare in Ipca Laboratories vs Alembic Pharmaceuticals?

Ans. The PE ratio comparison is covered in the data table above. Verify current figures from NSE or BSE before investing.

What is the ROE of Ipca Laboratories?

Ans. The ROE of Ipca Laboratories is mentioned in the data table above. Verify from the latest quarterly filings.

Does Alembic Pharmaceuticals pay dividends?

Ans. Dividend yield information for Alembic Pharmaceuticals is included in the comparison above. Verify from NSE or BSE.

How should I evaluate Pharmaceuticals stocks?

Ans. For Pharmaceuticals stocks, review earnings quality, ROE trends, debt levels and sector outlook. Consult a SEBI-registered advisor (INH000013776) before investing.